Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity

Younossi, 2016, Global epidemiology of nonalcoholic fatty liver disease – meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, 64, 73, 10.1002/hep.28431 Chalasani, 2018, The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases, Hepatology, 67, 328, 10.1002/hep.29367 Petrick, 2015, Utility of ultrasound, transaminases, and visual inspection to assess nonalcoholic fatty liver disease in bariatric surgery patients, Obes Surg, 25, 2368, 10.1007/s11695-015-1707-6 Castera, 2019, Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease, Gastroenterology, 156, 1264, 10.1053/j.gastro.2018.12.036 Festi, 2004, Hepatic steatosis in obese patients: clinical aspects and prognostic significance, Obes Rev, 5, 27, 10.1111/j.1467-789X.2004.00126.x Masuoka, 2013, Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals, Ann N Y Acad Sci, 1281, 106, 10.1111/nyas.12016 Machado, 2006, Hepatic histology in obese patients undergoing bariatric surgery, J Hepatol, 45, 600, 10.1016/j.jhep.2006.06.013 Wong, 2018, Noninvasive biomarkers in NAFLD and NASH – current progress and future promise, Nat Rev Gastroenterol Hepatol, 15, 461, 10.1038/s41575-018-0014-9 Saadeh, 2002, The utility of radiological imaging in nonalcoholic fatty liver disease, Gastroenterology, 123, 745, 10.1053/gast.2002.35354 Wildman-Tobriner, 2018, Association between magnetic resonance imaging-proton density fat fraction and liver histology features in patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis, Gastroenterology, 155, 1428, 10.1053/j.gastro.2018.07.018 Kleiner, 2014, Hepatic pathology among patients without known liver disease undergoing bariatric surgery: observations and a perspective from the Longitudinal Assessment of Bariatric Surgery (LABS) study, Semin Liver Dis, 34, 98, 10.1055/s-0034-1371083 Rockey, 2009, Liver biopsy, Hepatology, 49, 1017, 10.1002/hep.22742 Barbois, 2017, Benefit–risk of intraoperative liver biopsy during bariatric surgery: review and perspectives, Surg Obes Relat Dis, 13, 1780, 10.1016/j.soard.2017.07.032 Rubio, 2007, Consenso Seedo 2007 Para La Evaluación Del Sobrepeso Y La Obesidad Y El Establecimiento De Criterios De Intervención Terapéutica, Rev Española Obes, 7 Matthews, 1985, Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883 Mathurin, 2006, The evolution of severe steatosis after bariatric surgery is related to insulin resistance, Gastroenterology, 130, 1617, 10.1053/j.gastro.2006.02.024 Kleiner, 2005, Design and validation of a histological scoring system for nonalcoholic fatty liver disease, Hepatology, 41, 1313, 10.1002/hep.20701 Bedossa, 2012, Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients, Hepatology, 56, 1751, 10.1002/hep.25889 Sheth, 2019, The HAALT non-invasive scoring system for NAFLD in obesity, Obes Surg, 10.1007/s11695-019-03880-x Campos, 2008, A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients, Hepatology, 47, 1916, 10.1002/hep.22241 Dixon, 2001, Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese, Gastroenterology, 121, 91, 10.1053/gast.2001.25540 Ulitsky, 2010, A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients, Obes Surg, 20, 685, 10.1007/s11695-010-0118-y Gholam, 2007, Nonalcoholic fatty liver disease in severely obese subjects, Am J Gastroenterol, 102, 399, 10.1111/j.1572-0241.2006.01041.x Tai, 2017, Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity, Surg Obes Relat Dis, 13, 686, 10.1016/j.soard.2016.11.028 Morita, 2015, Prevalence of non-alcoholic fatty liver disease and steatohepatitis risk factors in patients undergoing bariatric surgery, Obes Surg, 25, 2335, 10.1007/s11695-015-1696-5 Machado, 2013, Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal, J Hepatol, 58, 1007, 10.1016/j.jhep.2012.11.021 Oikonomou, 2018, Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?, Eur J Gastroenterol Hepatol, 30, 979, 10.1097/MEG.0000000000001191 Kwo, 2017, ACG clinical guideline: evaluation of abnormal liver chemistries, Am J Gastroenterol, 112, 18, 10.1038/ajg.2016.517 Fracanzani, 2008, Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes, Hepatology, 48, 792, 10.1002/hep.22429 Pulzi, 2011, New clinical score to diagnose nonalcoholic steatohepatitis in obese patients, Diabetol Metab Syndr, 3, 1, 10.1186/1758-5996-3-3 Verna, 2014, Liver biopsy at the time of bariatric surgery: a benefit for patients and the medical community, Semin Liver Dis, 34, 1, 10.1055/s-0034-1371549 Roeb, 2019, Nonalcoholic steatohepatitis (NASH) – current treatment recommendations and future developments, Z Gastroenterol, 57, 508, 10.1055/a-0784-8827